期刊文献+

盐酸埃他卡林对缺氧性肺动脉高压转化生长因子β1及其受体表达的影响 被引量:4

Effect of iptakalim hydrochloride on the expression of TGFβ_1 and its receptor in hypoxic pulmonary hypertension
下载PDF
导出
摘要 目的研究新型ATP敏感的钾通道开放剂(KATPCO)盐酸埃他卡林(IPT)对缺氧性肺动脉高压(HPH)肺组织转化生长因子β1(TGFβ1)及其受体表达的影响。方法SD大鼠随机分成IPT处理组1(对正常氧浓度饲养环境中的大鼠给予IPT1.5mg/kg灌胃)、IPT处理组2(对每日缺氧饲养的大鼠给予IPT1.5mg/kg灌胃)和正常对照组及HPH模型组(给予5ml/kg生理盐水灌胃)。测定各组大鼠肺组织TGFβ1及TGFβRⅠmRNA表达和肺血管平滑肌细胞TGFβ1及TGFβRⅠ阳性细胞数。结果HPH大鼠较正常大鼠肺组织TGFβ1转录水平mRNA的表达显著增加,而TGFβRⅠmRNA的表达减少。HPH大鼠肺血管平滑肌细胞TGFβ1蛋白质水平表达亦增加,而TGFβRⅠ阳性细胞数下降。IPT能显著抑制HPH组TGFβ1的表达。IPT显著上调HPH组TGFβRⅠ的表达。IPT处理组1与正常对照组大鼠比较,TGFβ1mRNA及TGFβ1阳性细胞数稍有下降;TGFβRⅠmRNA及TGFβRⅠ阳性细胞数稍有增加,但差异无显著性。结论HPH的增殖因素TGFβ增加。IPT可抑制HPH的这种增殖,可能的途径为TGFβ受体信号系统。 Objective To study the effects of a novel ATP sensitive potassium channel opener(K_ ATPCO) iptakalim hydrochloride(IPT) on the expression of transforming growth factor-beta 1(TGFβ1) and its receptor in hypoxic pulmonary hypertension(HPH). Methods SD rats were randomly divided into IPT treated group 1 (treated with IPT 1.5mg·kg -1·d -1 ig and exposured to normal baric condition) and 2 (IPT 1.5mg·kg -1·d -1ig and hypoxic condition),normal-controlled group and HPH-model group (treated with normal saline in a dose of 5.0ml·kg -1·d -1 ig and bred in normal baric condition and hypoxic condition respectively). mRNA expression of TGFβ_1 and transforming growth factor-beta type Ⅰ receptor(TGFβ RⅠ) were detected by reverse transcription polymerase chain reaction. TGFβ_1 and TGFβ RⅠ staining positive small pulmonary arterial smooth muscle cells(PASMC) were evaluated by S-P immunohistochemical analysis. Results TGFβ_1 mRNA expression and TGFβ_1 staining positive PASMC increased, but TGFβ RⅠ mRNA expression and TGFβ RⅠ staining positive PASMC decreased in HPH group compared with those in normal-controlled group. IPT significantly inhibited TGFβ_1 expression in HPH, as TGFβ_1 mRNA expression and TGFβ_1 staining positive PASMC decreased in IPT treated group 2. IPT remarkably up-regulated TGFβ RⅠ expression in HPH, as TGFβ RⅠ mRNA expression and TGFβ RⅠ staining positive PASMC elevated in IPT treated group 2. TGFβ1 expression elevated and TGFβ RⅠ expression reduced slightly in IPT treated group 1 compared with those in normal-controlled group.Conclusion Proliferating factors TGFβ_1 increases in HPH. IPT could inhibit the proliferation of HPH, which might be mediated through the TGFβ_1 and its receptor signal pathway.
出处 《江苏医药》 CAS CSCD 北大核心 2005年第6期427-429,共3页 Jiangsu Medical Journal
基金 国家创新药物研究重大项目(国家1035工程项目969010101) 江苏省科技社会发展基金(BJ2000051) 江苏省教育厅高校科研重点资助课题(KJB320009)
  • 相关文献

参考文献10

  • 1解卫平,王虹,汪海,李百周,胡刚.ATP敏感性钾通道开放剂埃他卡林对大鼠低氧性肺动脉高压的影响[J].中国应用生理学杂志,2003,19(1):4-7. 被引量:11
  • 2Wang H.Pharmacological characteristic of novel antihypertensive drug,iptakalim hydrochloride,and its molecular mechanisms.Drug Dev Res,2003,58:65-68.
  • 3吴巧珍,殷凯生,王祥,熊俊,德伟.咪喹莫特抑制哮喘大鼠气道炎症转录水平的研究[J].江苏医药,2003,29(3):176-178. 被引量:10
  • 4Attisano L,Wrana JL.Signal transduction by the TGF-beta superfamily.Science,2002,296:1646-1647.
  • 5Post M,Tanswell K.Embryonic lung development.In:Wardlaw AJ,Hamid Q,eds.Textbook of respiratory cell and molecular biology.London:Martin Dunitz Ptess,2002.9-10.
  • 6Utsugi M,Dobashi K,Ishizuka T,et al.C-Jun-NH2-terminal kinase mediates expression of connective tissue growth factor induced by transforming growth factor-beta1 in human lung fibroblasts.Am J Respir Cell Mol Biol,2003,28:754-761.
  • 7Berk BC.Vascular smooth muscle growth:autocrine growth mechanisms.Physiol Rev,2001,81:999-1029.
  • 8Lane KB,Machado RD,Pauciulo MW,et al.Heterozygous germline mutations in BMPR2,encoding a TGF-beta receptor,cause familial primary pulmonary hypertension.The international PPH consortium.Nat Genet,2000,26:81-84.
  • 9Newman JH,Wheeler L,Lane KB,et al.Mutation in the gene for bone morphogenetic protein receptor Ⅱ as a cause of primary pulmonary hypertension in a large kindred.N Engl J Med,2001,345:319-324.
  • 10Moustakas A,Souchelnytskyi S,Heldin CH.Smard regulation in TGF-beta signal transduction.J Cell Sci,2001,114:4359-4369.

二级参考文献15

  • 1[1]Huang TJ,MacAry PA,Eynott P,et al.Allergen-specific Th1 cells counteract efferent Th2 cell-dependent bronchial hyperresponsiveness and eosinophilic inflammation partly via IFN-γ.J Immunol,2001,166:207-217.
  • 2[2]Wegner TL,Ahonen CL,Conture AM,et al.Modulation of TH1 and TH2 cytokine production with the immune response modifiers,R-848 and imiquimod.Cell Immunol,1998,191:10-19.
  • 3[3]Wong CK,Ho CY,Ko FW,et al.Proinflammatory cytokines(IL-17,IL-6,IL-18 and IL-12)and Th cytokines(IFN-gamma,IL- 4,IL-10 and IL-13) in patients with allergic asthma.Clin Exp Immunol,2001,125:177-183.
  • 4[4]Bates ME,Busse WW,Bertics PJ.Interleukin 5 signals through Shc and Grb2 in human eosinophils.Am J Respir Cell Mol Biol,1998,18:75-83.
  • 5[1]Jeffery T K, Wanstall J C. Pulmonary vascular remodeling: a target for therapeutic intervention in pulmonary hypertension[J]. Pharmacol Thera Peutics,2001,92:1-20.
  • 6[2]Sato K, Morio Y, Morris K G, et al. Mechanism of hypoxic pulmonary vasoconstriction involves ET(A) receptor-mediated inhibition of K(ATP) channel[J]. Am J Physiol Lung Cell Mol Physiol,2000,278:L434-442.
  • 7[3]Hayabuchi Y, Davies N W, Standen N B. Angiotensin Ⅱ inhibits rat arterial KATP channels by inhibiting steady-state protein kinase A activity and activationg protein kinase Ce[J]. J Physiol, 2001, 530(Pt2):193-205.
  • 8[4]Jeffery T K, Wanstall J C. Perindopril, an angiotensin converting enzyme inhibitor, in pulmonary hypertensive rats: comparative effects on pulmonary vascular structure and function[J]. Br J Pharmacol, 1999,128:1407-1418.
  • 9[5]Jeffery T K, Wanstall J C. Pulmonary vascular remodeling in hypoxic rats: effects of amlodipine, alone and with perindopril[J]. Eur J Pharmacol,2001,416:123-131.
  • 10[6]Zhao L, Al-Tubuly R, Sebkhi A, et al. Angiotensin Ⅱ receptor expression and inhibition in the chronically hypoxic rat lung[J]. Br J Pharmacol,1996,119:1217-1222.

共引文献18

同被引文献34

  • 1王虹,王祥,解卫平.埃他卡林对低氧性肺动脉高压肺组织增殖细胞核抗原表达的抑制作用[J].医药导报,2005,24(1):7-9. 被引量:4
  • 2倪布清,张石江,朱煜明,张宁,王虹,解卫平.新型KATP通道开放剂埃他卡林对人肺动脉平滑肌细胞增殖的影响[J].国际呼吸杂志,2007,27(12):903-906. 被引量:5
  • 3Seino S, Miki T. Physiological and pathophysiological roles of ATP-sensitive K^+ channels. Prog Biophys Mol Biol, 2003,81: 133-176.
  • 4Wang H. Pharmacological characteristics of the novel antihypertensive drug iptakalim hydrochloride and its molecular mechanisms. Drug Dev Res, 2003,58:65-68.
  • 5Xie W, Wang H, Wang H, et al. Effects of iptakalim hydrochloride, a novel KATP channel opener, on pulmonary vascular remodeling in hypoxic rats. Life Sci,2004,75:2065-2076.
  • 6Mandegar M, Yuan JX. Role of K^+ channels in pulmonary hypertension, Vascul Pharmacol, 2002,38: 25-33.
  • 7Opitz CF,Ewert R. Dual ET(A)/ET(B) vs. selective ET(A) endothelin receptor antagonism in patients with pulmonary hypertension. Eur J Clin Invest,2006,36(Suppl 3) : 1-9.
  • 8Livak KJ,Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2 (-Delta Deltu C (T)) method. Methods,2001,25:402-408.
  • 9Michelakis ED, Weir EK. The pathobiology of pulmonary hypertension. Smooth muscle cells and ion channels. Clin Chest Med,2001,22:419-432.
  • 10Cole WC,Clement-Chomienne O. ATP-sensitive K^+ channels of vascular smooth muscle cells. J Cardiovasc Electrophysiol,2003, 14:94-103.

引证文献4

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部